{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:58:06Z","timestamp":1782867486384,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-6681-9","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T23:02:52Z","timestamp":1556060572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-8073","authenticated-orcid":false,"given":"Allison","family":"DeLong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayla","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Kotsoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"issue":"4552","key":"6681_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.7043737","volume":"216","author":"W Burgdorfer","year":"1982","unstructured":"Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science. 1982;216(4552):1317\u20139.","journal-title":"Science."},{"key":"6681_CR2","unstructured":"CDC. Lyme Disease statistics: Centers for Disease Control and Prevention; 2016 [Available from: \n                    https:\/\/www.who.int\/mediacentre\/factsheets\/fs387\/en\/index10.html\n                    \n                  ."},{"issue":"5","key":"6681_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciu397","volume":"59","author":"AF Hinckley","year":"2014","unstructured":"Hinckley AF, Connally NP, Meek JI, Johnson BJ, Kemperman MM, Feldman KA, et al. Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis. 2014;59(5):676\u201381.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"6681_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3201\/eid2109.150417","volume":"21","author":"CA Nelson","year":"2015","unstructured":"Nelson CA, Saha S, Kugeler KJ, Delorey MJ, Shankar MB, Hinckley AF, et al. Incidence of clinician-diagnosed Lyme disease, United States, 2005-2010. Emerg Infect Dis. 2015;21(9):1625\u201331.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"6681_CR5","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","volume":"17","author":"JN Aucott","year":"2013","unstructured":"Aucott JN, Crowder LA, Kortte KB. Development of a foundation for a case definition of post-treatment Lyme disease syndrome. Int J Infect Dis. 2013;17(6):e443\u20139.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"6681_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089\u2013134.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"6681_CR7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/ije\/dyi129","volume":"34","author":"V Cairns","year":"2005","unstructured":"Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005;34(6):1340\u20135.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"6681_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.idc.2015.02.012","volume":"29","author":"JN Aucott","year":"2015","unstructured":"Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin N Am. 2015;29(2):309\u201323.","journal-title":"Infect Dis Clin N Am"},{"issue":"2","key":"6681_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116767","volume":"10","author":"ER Adrion","year":"2015","unstructured":"Adrion ER, Aucott J, Lemke KW, Weiner JP. Health care costs, utilization and patterns of care following Lyme disease. PLoS One. 2015;10(2):e0116767.","journal-title":"PLoS One"},{"issue":"6","key":"6681_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/eurpub\/ckv091","volume":"25","author":"CC Wijngaard van den","year":"2015","unstructured":"van den Wijngaard CC, Hofhuis A, Harms MG, Haagsma JA, Wong A, de Wit GA, et al. The burden of Lyme borreliosis expressed in disability-adjusted life years. Eur J Pub Health. 2015;25(6):1071\u20138.","journal-title":"Eur J Pub Health"},{"issue":"2","key":"6681_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canep.2014.02.005","volume":"38","author":"S Crouch","year":"2014","unstructured":"Crouch S, Smith A, Painter D, Li J, Roman E. Determining disease prevalence from incidence and survival using simulation techniques. Cancer Epidemiol. 2014;38(2):193\u20139.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"6681_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.1780200102","volume":"20","author":"AC Steere","year":"1977","unstructured":"Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20(1):7\u201317.","journal-title":"Arthritis Rheum"},{"issue":"14","key":"6681_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMra072023","volume":"357","author":"HM Feder Jr","year":"2007","unstructured":"Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP, et al. A critical appraisal of \"chronic Lyme disease\". N Engl J Med. 2007;357(14):1422\u201330.","journal-title":"N Engl J Med"},{"key":"6681_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fmed.2017.00224","volume":"4","author":"AW Rebman","year":"2017","unstructured":"Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, et al. The clinical, symptom, and quality-of-life characterization of a well-defined Group of Patients with posttreatment Lyme disease syndrome. Front Med (Lausanne). 2017;4:224.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"6681_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.idc.2007.12.011","volume":"22","author":"A Marques","year":"2008","unstructured":"Marques A. Chronic Lyme disease: a review. Infect Dis Clin N Am. 2008;22(2):341\u201360 vii-viii.","journal-title":"Infect Dis Clin N Am"},{"issue":"3","key":"6681_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/cid\/ciq157","volume":"52","author":"KJ Kugeler","year":"2011","unstructured":"Kugeler KJ, Griffith KS, Gould LH, Kochanek K, Delorey MJ, Biggerstaff BJ, et al. A review of death certificates listing Lyme disease as a cause of death in the United States. Clin Infect Dis. 2011;52(3):364\u20137.","journal-title":"Clin Infect Dis"},{"key":"6681_CR17","unstructured":"CDC. Mortality Tables: Centers for Disease Control and Prevention; [US mortality data]. Available from: \n                    https:\/\/www.cdc.gov\/nchs\/nvss\/mortality_tables.htm\n                    \n                  ."},{"key":"6681_CR18","unstructured":"CDC. Cause of death: Centers for Disease Control and Prevention; [Available from: \n                    https:\/\/www.cdc.gov\/nchs\/data\/statab\/gm290-98.pdf\n                    \n                  ."},{"issue":"22","key":"6681_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","volume":"66","author":"AM Schwartz","year":"2017","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme disease - United States, 2008-2015. MMWR Surveill Summ. 2017;66(22):1\u201312.","journal-title":"MMWR Surveill Summ"},{"key":"6681_CR20","doi-asserted-by":"crossref","unstructured":"Hahn, MB, Jarnevich, CS, Monaghan, AJ and Eisen, RJ. Modeling the Geographic Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Contiguous United States. J Med Entomol. 2016;53(5):1176\u201391.","DOI":"10.1093\/jme\/tjw076"},{"key":"6681_CR21","unstructured":"CDC. What you need to know about Lyme carditis: Centers for Disease Control and Prevention; 2018 [Available from: \n                    https:\/\/www.cdc.gov\/lyme\/signs_symptoms\/lymecarditis.html\n                    \n                  ."},{"issue":"7","key":"6681_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/cid\/ciu411","volume":"59","author":"JD Forrester","year":"2014","unstructured":"Forrester JD, Mead P. Third-degree heart block associated with Lyme carditis: review of published cases. Clin Infect Dis. 2014;59(7):996\u20131000.","journal-title":"Clin Infect Dis"},{"key":"6681_CR23","unstructured":"R: a language and environment for statistical computing. Vienna, Austria.: R Core team. R Foundation for statistical computing.; 2018 [Available from: \n                    https:\/\/www.r-project.org\/\n                    \n                  ."},{"issue":"2","key":"6681_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2015.02.006","volume":"29","author":"PM Lantos","year":"2015","unstructured":"Lantos PM. Chronic Lyme disease. Infect Dis Clin N Am. 2015;29(2):325\u201340.","journal-title":"Infect Dis Clin N Am"},{"issue":"12","key":"6681_CR25","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/cid\/civ735","volume":"61","author":"E Weitzner","year":"2015","unstructured":"Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, et al. Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease. Clin Infect Dis. 2015;61(12):1800\u20136.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"6681_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CVI.00071-16","volume":"23","author":"JN Aucott","year":"2016","unstructured":"Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, et al. CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study. Clin Vaccine Immunol. 2016;23(9):757\u201366.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"6681_CR27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cid\/cit735","volume":"58","author":"K Strle","year":"2014","unstructured":"Strle K, Stupica D, Drouin EE, Steere AC, Strle F. Elevated levels of IL-23 in a subset of patients with post-Lyme disease symptoms following erythema migrans. Clin Infect Dis. 2014;58(3):372\u201380.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"6681_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/cid\/ciw599","volume":"63","author":"M Uhde","year":"2016","unstructured":"Uhde M, Ajamian M, Li X, Wormser GP, Marques A, Alaedini A. Expression of C-reactive protein and serum amyloid a in early to late manifestations of Lyme disease. Clin Infect Dis. 2016;63(11):1399\u2013404.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"6681_CR29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/art.34383","volume":"64","author":"K Strle","year":"2012","unstructured":"Strle K, Shin JJ, Glickstein LJ, Steere AC. Association of a toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum. 2012;64(5):1497\u2013507.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6681_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","volume":"115","author":"J Nowakowski","year":"2003","unstructured":"Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115(2):91\u20136.","journal-title":"Am J Med"},{"issue":"12","key":"6681_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","volume":"131","author":"NA Shadick","year":"1999","unstructured":"Shadick NA, Phillips CB, Sangha O, Logigian EL, Kaplan RF, Wright EA, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med. 1999;131(12):919\u201326.","journal-title":"Ann Intern Med"},{"issue":"3","key":"6681_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/318082","volume":"183","author":"RA Kalish","year":"2001","unstructured":"Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC. Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis. 2001;183(3):453\u201360.","journal-title":"J Infect Dis"},{"issue":"3","key":"6681_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ajpath.2017.11.005","volume":"188","author":"NA Crossland","year":"2018","unstructured":"Crossland NA, Alvarez X, Embers ME. Late disseminated Lyme disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques. Am J Pathol. 2018;188(3):672\u201382.","journal-title":"Am J Pathol"},{"issue":"10","key":"6681_CR34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1086\/345284","volume":"186","author":"LK Bockenstedt","year":"2002","unstructured":"Bockenstedt LK, Mao J, Hodzic E, Barthold SW, Fish D. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J Infect Dis. 2002;186(10):1430\u20137.","journal-title":"J Infect Dis"},{"issue":"13","key":"6681_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","volume":"374","author":"A Berende","year":"2016","unstructured":"Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374(13):1209\u201320.","journal-title":"N Engl J Med"},{"issue":"5","key":"6681_CR36","first-page":"489","volume":"99","author":"D Cameron","year":"2008","unstructured":"Cameron D. Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med. 2008;99(5):489\u201396.","journal-title":"Minerva Med"},{"issue":"12","key":"6681_CR37","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923\u201330.","journal-title":"Neurology."},{"issue":"13","key":"6681_CR38","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","volume":"70","author":"BA Fallon","year":"2008","unstructured":"Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992\u20131003.","journal-title":"Neurology."},{"issue":"6","key":"6681_CR39","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","volume":"33","author":"AK Delong","year":"2012","unstructured":"Delong AK, Blossom B, Maloney EL, Phillips SE. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012;33(6):1132\u201342.","journal-title":"Contemp Clin Trials"},{"key":"6681_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbi.2015.04.006","volume":"48","author":"M Ajamian","year":"2015","unstructured":"Ajamian M, Cooperstock M, Wormser GP, Vernon SD, Alaedini A. Anti-neural antibody response in patients with post-treatment Lyme disease symptoms versus those with myalgic encephalomyelitis\/chronic fatigue syndrome. Brain Behav Immun. 2015;48:354\u20135.","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"6681_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","volume":"255","author":"E Jacek","year":"2013","unstructured":"Jacek E, Fallon BA, Chandra A, Crow MK, Wormser GP, Alaedini A. Increased IFNalpha activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. J Neuroimmunol. 2013;255(1\u20132):85\u201391.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"6681_CR42","doi-asserted-by":"publisher","first-page":"e00100","DOI":"10.1128\/mBio.00100-16","volume":"7","author":"J Bouquet","year":"2016","unstructured":"Bouquet J, Soloski MJ, Swei A, Cheadle C, Federman S, Billaud JN, et al. Longitudinal transcriptome analysis reveals a sustained differential gene expression signature in patients treated for acute Lyme disease. MBio. 2016;7(1):e00100\u201316.","journal-title":"MBio."},{"issue":"12","key":"6681_CR43","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/cid\/ciu703","volume":"59","author":"BA Fallon","year":"2014","unstructured":"Fallon BA, Pavlicova M, Coffino SW, Brenner C. A comparison of Lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment. Clin Infect Dis. 2014;59(12):1705\u201310.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"6681_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168613","volume":"11","author":"LA Waddell","year":"2016","unstructured":"Waddell LA, Greig J, Mascarenhas M, Harding S, Lindsay R, Ogden N. The accuracy of diagnostic tests for Lyme disease in humans, a systematic review and meta-analysis of north American research. PLoS One. 2016;11(12):e0168613.","journal-title":"PLoS One"},{"issue":"10","key":"6681_CR45","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/CVI.00109-08","volume":"15","author":"GP Wormser","year":"2008","unstructured":"Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol. 2008;15(10):1519\u201322.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"6681_CR46","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3201\/eid2108.141878","volume":"21","author":"KJ Kugeler","year":"2015","unstructured":"Kugeler KJ, Farley GM, Forrester JD, Mead PS. Geographic distribution and expansion of human Lyme disease, United States. Emerg Infect Dis. 2015;21(8):1455\u20137.","journal-title":"Emerg Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6681-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6681-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6681-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T23:07:32Z","timestamp":1587596852000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6681-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6681"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6681-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mayla Hsu, Ph.D. is the Director of Research and Science at Global Lyme Alliance, a nonprofit organization. Harriet O. Kotsoris, M.D. was formerly associated with Global Lyme Alliance on a volunteer basis, and from time to time advises one or more other nonprofit organizations in connection with tick-borne diseases. The authors declare that they have no competing interests.The views and opinions expressed here are those of the authors and do not necessarily reflect the official policy or position of Brown University or Global Lyme Alliance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"352"}}